Goldschmidt N - Search Results

1

Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.

Vine J, Cohen SB, Ruchlemer R, Goldschmidt N, Levin M, Libster D, Gural A, Gatt ME, Lavie D, Ben-Yehuda D, Rund D. Vine J, et al. Among authors: goldschmidt n. Leuk Lymphoma. 2014 Nov;55(11):2525-31. doi: 10.3109/10428194.2014.893307. Epub 2014 Mar 19. Leuk Lymphoma. 2014. PMID: 24524306

2

Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia.

Goldschmidt N, Gural A, Ben Yehuda D. Goldschmidt N, et al. Leuk Lymphoma. 2003 Aug;44(8):1433-7. doi: 10.1080/1042819031000076963. Leuk Lymphoma. 2003. PMID: 12952241 Review.

3

High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.

Ganzel C, Gatt ME, Maly A, Ben-Yehuda D, Goldschmidt N. Ganzel C, et al. Among authors: goldschmidt n. Leuk Lymphoma. 2012 Jun;53(6):1169-73. doi: 10.3109/10428194.2011.635864. Epub 2011 Dec 7. Leuk Lymphoma. 2012. PMID: 22035415

4

Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib.

Goldschmidt N, Rund D. Goldschmidt N, et al. Leuk Lymphoma. 2017 Feb;58(2):498-500. doi: 10.1080/10428194.2016.1182163. Epub 2016 Oct 18. Leuk Lymphoma. 2017. PMID: 27756158 No abstract available.

5

Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein.

Cukierman T, Gatt ME, Libster D, Goldschmidt N, Matzner Y. Cukierman T, et al. Among authors: goldschmidt n. Leuk Lymphoma. 2002 Sep;43(9):1865-8. doi: 10.1080/1042819021000006367. Leuk Lymphoma. 2002. PMID: 12685846

6

Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia.

Goldschmidt N, Gural A, Ben-Yehuda D, Gatt ME. Goldschmidt N, et al. Cancer Chemother Pharmacol. 2013 Sep;72(3):709-13. doi: 10.1007/s00280-013-2243-5. Epub 2013 Aug 2. Cancer Chemother Pharmacol. 2013. PMID: 23907444

7

Influence of ethnicity and improved outcome of acute myeloid leukaemia: two decades of follow-up of Israeli patient cohort.

Goldschmidt N, Cohen SB, Gatt ME, Safrai M, Rund D. Goldschmidt N, et al. Hematol Oncol. 2014 Jun;32(2):94-101. doi: 10.1002/hon.2092. Epub 2013 Sep 3. Hematol Oncol. 2014. PMID: 24038510

8

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

Goldschmidt N, Kleinstern G, Orevi M, Paltiel O, Ben-Yehuda D, Gural A, Libster D, Lavie D, Gatt ME. Goldschmidt N, et al. Cancer Chemother Pharmacol. 2016 May;77(5):1053-60. doi: 10.1007/s00280-016-3024-8. Epub 2016 Apr 7. Cancer Chemother Pharmacol. 2016. PMID: 27056383

9

The prognostic value of bone marrow involvement at the molecular level in aggressive lymphoma.

Goldschmidt N, Darawshy F, Kleinstern G, Slyusarevsky E, Pogrebijski G, Krichevsky S, Ben-Yehuda D, Gatt ME. Goldschmidt N, et al. Leuk Lymphoma. 2017 Jan;58(1):45-52. doi: 10.1080/10428194.2016.1201569. Epub 2016 Oct 18. Leuk Lymphoma. 2017. PMID: 27756163

10

Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis.

Pick M, Vainstein V, Goldschmidt N, Lavie D, Libster D, Gural A, Grisariu S, Avni B, Ben Yehuda D, Gatt ME. Pick M, et al. Among authors: goldschmidt n. Eur J Haematol. 2018 May;100(5):494-501. doi: 10.1111/ejh.13046. Epub 2018 Mar 25. Eur J Haematol. 2018. PMID: 29453884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters